HJP 272

Overview

HJP 272 is a selective endothelin peptide A ( ET A ) receptor antagonist with an IC 50 of 37.01 nM. . HJP 272 can be used for the researches of pulmonary arterial hypertension, fibrosis, renal failure and cancer .

Application

Products | Products > Disease Areas > Renal Failure | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Renal Disease | Products > Disease Areas > Pulmonary Hypertension | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Endothelin Receptor

Product Information

• Catalog No.: HY-183141
• CAS No.: 1072467-37-8
• Molecular Formula: C28H23NO8
• Molecular Weight: 501.48
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source